In the last 12 months, insiders at XBiotech Inc. ($XBIT) filed 16 transactions with the SEC: 1 open-market purchases totaling $10,000,000 and 0 sales totaling $0. Net insider sentiment: net buying.
XBiotech Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- SIMARD JOHN (Chief Executive Officer) — 3 transactions totaling $20,000,000
- MacAdam Donald H. (Director) — 1 transaction totaling $0
- Rademaker Craig Evan (Not found) — 1 transaction totaling $0
- Libby Peter (Director) — 1 transaction totaling $0
- Libby Peter (Not found) — 1 transaction totaling $0
View all SEC Filings for XBiotech Inc. (XBIT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 1, 2025 | Rademaker Craig Evan | Not found | A | Director Stock Option | 92104 | $0.00 | 92,104.0000 | 30,487,731 | 9999.99% | 0.30% |
| Oct. 1, 2025 | Troy Tevi David | Not found | A | Director Stock Option | 56000 | $0.00 | 56,000.0000 | 30,487,731 | 9999.99% | 0.18% |
| Oct. 1, 2025 | Kuendig Thomas Martin | Not found | A | Director Stock Option | 79115 | $0.00 | 79,115.0000 | 30,487,731 | 9999.99% | 0.26% |
| Oct. 1, 2025 | Soffer David Spencer | Not found | A | Director Stock Option | 51000 | $0.00 | 51,000.0000 | 30,487,731 | 9999.99% | 0.17% |
| March 17, 2025 | SIMARD JOHN | Chief Executive Officer | A | Stock Option | 1026228 | $0.00 | 1,896,609.0000 | 0 | 117.91% | 0.00% |
| Jan. 31, 2025 | SIMARD JOHN | Chief Executive Officer | J | Convertible Loan Agreement | 2470355 | $10000000.00 | 870,381.0000 | 0 | 73.95% | 0.00% |
| June 20, 2024 | MacAdam Donald H. | Not found | A | Director Stock Option | 37500 | $0.00 | 37,500.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Waldin Jan-Paul | Not found | A | Director Stock Option | 37500 | $0.00 | 37,500.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | MCKENZIE W THORPE | Not found | A | Director Stock Option | 37500 | $0.00 | 37,500.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Libby Peter | Not found | A | Director Stock Option | 37500 | $0.00 | 37,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2024 | SIMARD JOHN | Chief Executive Officer | P | Convertible Loan Agreement | 2470355 | $10000000.00 | 3,840,736.0000 | 0 | 180.27% | 0.00% |
| June 23, 2023 | Waldin Jan-Paul | Director | A | Director Stock Option | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2023 | Libby Peter | Director | A | Director Stock Option | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2023 | MacAdam Donald H. | Director | A | Director Stock Option | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2023 | MCKENZIE W THORPE | Director | A | Director Stock Option | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2023 | SHIVASWAMY SUSHMA | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |